S1095 The Pharmacokinetics of TAK-390mr 60 mg, a Dual Delayed Release Formulation of the Proton Pump Inhibitor TAK-390, and Lansoprazole 60 mg: A Retrospective Analysis

Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy

10.1111/j.1365-2036.2009.03984.x ◽

2009 ◽

Vol 29 (9) ◽

pp. 928-937 ◽

Cited By ~ 78

Author(s):

D. C. METZ ◽

M. VAKILY ◽

T. DIXIT ◽

D. MULFORD

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Proton Pump Inhibitor Therapy ◽

Review Article ◽

Inhibitor Therapy ◽

Release Formulation ◽

Delayed Release ◽

Novel Approach

Drug Interaction Studies with Dexlansoprazole Modified Release (TAK-390MR), a Proton Pump Inhibitor with a Dual Delayed-Release Formulation

Clinical Drug Investigation ◽

10.2165/0044011-200929010-00004 ◽

2009 ◽

Vol 29 (1) ◽

pp. 35-50 ◽

Cited By ~ 24

Author(s):

Majid Vakily ◽

Ronald D Lee ◽

Jingtao Wu ◽

Lhanoo Gunawardhana ◽

Darcy Mulford

Keyword(s):

Drug Interaction ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Modified Release ◽

Release Formulation ◽

Delayed Release ◽

Interaction Studies

Faculty Opinions recommendation of Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation--results from two randomized controlled studies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1159205.619527 ◽

2009 ◽

Author(s):

Philip O Katz ◽

Ellen Stein

Keyword(s):

Clinical Trials ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Erosive Oesophagitis ◽

Release Formulation ◽

Randomized Controlled ◽

Delayed Release ◽

Randomized Controlled Studies

Gastric Biopsy Results From Patients Treated With Dexlansoprazole MR, a Proton Pump Inhibitor with a Dual Delayed Release Formulation

The American Journal of Gastroenterology ◽

10.14309/00000434-200910003-00013 ◽

2009 ◽

Vol 104 ◽

pp. S5

Author(s):

Mary Bronner ◽

Claudia M. Perez ◽

Aruna Dabholkar ◽

William Palo

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Gastric Biopsy ◽

Release Formulation ◽

Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation - results from two randomized controlled studies

10.1111/j.1365-2036.2009.03933.x ◽

2009 ◽

Vol 29 (7) ◽

pp. 731-741 ◽

Cited By ~ 80

Author(s):

P. SHARMA ◽

N. J. SHAHEEN ◽

M. C. PEREZ ◽

B. L. PILMER ◽

M. LEE ◽

...

Keyword(s):

Clinical Trials ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Erosive Oesophagitis ◽

Release Formulation ◽

Randomized Controlled ◽

Delayed Release ◽

Randomized Controlled Studies

Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience

10.1111/j.1365-2036.2009.04137.x ◽

2009 ◽

Vol 30 (10) ◽

pp. 1010-1021 ◽

Cited By ~ 20

Author(s):

D. A. PEURA ◽

D. C. METZ ◽

A. H. DABHOLKAR ◽

M. M. PARIS ◽

P. YU ◽

...

Keyword(s):

Clinical Trial ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Safety Profile ◽

Release Formulation ◽

Delayed Release ◽

Trial Experience ◽

Global Clinical Trial ◽

Clinical Trial Experience

Impact of Baseline La Grade on Healing of Erosive Esophagitis (EE) Following Treatment with TAK-390MR, a Proton Pump Inhibitor (PPI) with a Novel Dual Delayed Release Formulation, Compared with Lansoprazole (Lan)

The American Journal of Gastroenterology ◽

10.14309/00000434-200809001-00024 ◽

2008 ◽

Vol 103 ◽

pp. S10-S11 ◽

Cited By ~ 1

Author(s):

Nicholas Shaheen ◽

David Peura ◽

M. Claudia Perez ◽

Betsy Pilmer ◽

Galen Witt ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Erosive Esophagitis ◽

Release Formulation ◽

S1074 Tak-390MR, a Proton Pump Inhibitor with a Novel Dual Delayed Release Formulation, Maintains Healing and Controls Heartburn in GERD Patients with Healed Erosive Esophagitis

Gastroenterology ◽

10.1016/s0016-5085(08)60798-2 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-171

Author(s):

David C. Metz ◽

Colin W. Howden ◽

Maria Claudia Perez ◽

Lois M. Larsen ◽

Janet M. O'Neil

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Erosive Esophagitis ◽

Release Formulation ◽

Effects of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor, on Plasma Gastrin Levels in Healthy Subjects

The Journal of Clinical Pharmacology ◽

10.1177/0091270008330155 ◽

2009 ◽

Vol 49 (4) ◽

pp. 444-454 ◽

Cited By ~ 9

Author(s):

Weijiang Zhang ◽

Jingtao Wu ◽

Stuart N. Atkinson

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Healthy Subjects ◽

Plasma Gastrin ◽

Release Formulation ◽

The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease

10.1111/j.1365-2036.2010.04519.x ◽

2010 ◽

Vol 33 (3) ◽

pp. 366-377 ◽

Cited By ~ 5

Author(s):

A. H. Dabholkar ◽

C. Han ◽

M. M. Paris ◽

M. C. Perez ◽

S. N. Atkinson ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Reflux Disease ◽

Safety Profile ◽

Oesophageal Reflux ◽

Release Formulation ◽

Delayed Release ◽

Oesophageal Reflux Disease